Why 2026 Will Be a Defining Year for Global Biotech Collaboration The biotechnology industry is entering 2026 at a critical inflection point. After years of accelerated innovation driven by global health challenges, supply chain disruptions, and rapid digital transformation, the focus
Novartis and Relation Therapeutics Enter Strategic Collaboration to Advance Atopic Disease Treatments United Kingdom - 12 Dec 2025: UK-based biotech company Relation Therapeutics has announced a strategic, multi-program collaboration with Novartis aimed at accelerating the discovery and development of new therapies for
Reprocessed Nuclear Material to Support Next-Generation Cancer Therapies in the UK United Kingdom - 17 Dec, 2025: A pioneering collaboration between the UK’s life sciences and nuclear sectors is set to unlock a new pathway for advanced cancer treatment, with
Collaboration Models That Work: How Academia, Big Pharma & Startups Are Co-Innovating In today’s fast-moving biotechnology landscape, breakthrough innovation rarely comes from one organisation alone. The most transformative discoveries, whether in gene therapies, AI-driven drug discovery, cell and gene manufacturing, or
EASEE4YOU Clinical Study Begins in the UK as GOSH Joins Evaluation of New Neurostimulation Therapy London, 11 Dec 2025: A major European clinical study, EASEE4YOU, is preparing to launch in the UK, with Great Ormond Street Hospital (GOSH) joining the international research effort. The study
Newcastle Launches the UK’s First National Centre for Neurotechnology and Neurorestoration United Kingdom - 03 Dec 2025: Experts from Newcastle Hospitals, in collaboration with Newcastle University, have established the National Centre for Neurotechnology and Neurorestoration, the UK’s first dedicated facility
UK and US Finalise Zero-Tariff Deal on Pharmaceuticals to Boost Investment and Market Access United Kingdom - 01 Dec, 2025: The United States and the United Kingdom have reached a landmark agreement that will eliminate tariffs on British pharmaceutical products and medical technologies, marking
The Evolving Regulatory Landscape: What MHRA and EMA Advancements Mean for Biotech Innovators The biotechnology industry is in a transformative phase, propelled by recent, forward-looking regulatory updates across the UK and EU that make it easier to develop, manufacture and bring novel therapies
UK–Canada Collaboration Advances New Anti-Biofilm Therapies United Kingdom - 25 Nov 2025: University of Cambridge spin-out BioTryp Therapeutics has joined forces with Montreal-based preclinical drug discovery research company, Intellisyn Pharma, to accelerate the development of next-generation
CPI Collaborates on £44.9 Million Projects to Advance Sustainable Medicines Manufacturing United Kingdom - November 18, 2025: The Innovate UK Sustainable Medicines Manufacturing Innovation Programme (SMMIP) has announced funding for eight pioneering R&D initiatives designed to push forward cleaner,
Convatec to Invest £500 Million in New UK R&D Hub in Manchester November 10, 2025: Convatec has announced plans to expand its research and development (R&D) presence in the United Kingdom with a £500 million investment over the next decade.
Cizzle Biotech Signs Agreement to Bring Early Lung Cancer Blood Test to the NHS London, UK – 05 November 2025: British biotechnology company Cizzle Biotechnology Holdings plc (LSE: CIZ) has taken a major step toward transforming lung cancer diagnosis in the UK. The company has
NHS Set to Trial AI System to Improve Prostate Cancer Diagnosis and Treatment United Kingdom, 03 Nov 2025: A new artificial intelligence tool designed to support prostate cancer diagnosis and treatment planning will soon be trialled across NHS hospitals, scientists have revealed. The
UK Government’s £55 Billion R&D Boost to Accelerate Healthcare Innovation London, 30 October 2025: The UK Government has announced a landmark £55 billion R&D funding allocation to strengthen the nation’s position as a global leader in science,
UK’s First MS Patient Receives CAR T Cell Therapy in Groundbreaking UCL Trial London, 24 Oct 2025: A patient with multiple sclerosis (MS) in the UK has become the first to receive CAR T cell therapy, an innovative treatment developed by researchers at
